£124.81

Wiley Chronic Obstructive Pulmonary Disease: Pathogenesis to Treatment: 234 (Novartis Foundation Symposia)

Price data last checked 16 day(s) ago - will refresh soon

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£125 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 75 days · 75 data points (no recent data)

Historical
Generating forecast…
£132.66 £124.03 £125.91 £127.79 £129.68 £131.56 £133.45 25 April 2026 13 May 2026 01 June 2026 19 June 2026 08 July 2026

Price Distribution

Price distribution over 75 days • 4 price levels

Days at Price
Current Price
50 days 12 days 3 days 10 days 0 13 25 38 50 £125 £128 £129 £133 Days at Price

Price Analysis

Most common price: £125 (50 days, 66.7%)

Price range: £125 - £133

Price levels: 4 different prices over 75 days

Description

Chronic obstructive pulmonary disease (COPD) is the most common respiratory disorder of adults in the developed world and is the fourth main cause of death in the USA. It is also associated with high morbidity, and poses an enormous burden of suffering and expense. Despite this, the disease has received little attention compared with other respiratory conditions such as asthma and lung cancer. Current treatment can offer some marginal symptomatic relief but does not address the underlying disease process. Indeed, smoking cessation is the only intervention known to alter the rate of disease progression. There is clearly great need, and potential, for the development of superior therapies for symptomatic relief and disease modification. This book brings together leading researchers and physicians to discuss the most recent advances in our understanding of COPD, and draws together basic and clinical aspects relevant to the topic. Coverage includes the basic pathology, current and potential therapies, and detailed consideration of the major theories for the pathogenesis of COPD.

Product Specifications

Brand
Wiley
Format
hardcover
Domain
Amazon UK
Release Date
28 November 2000
Listed Since
09 February 2007

Barcode

No barcode data available